# 36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent DILI

> **NCT03266146** · PHASE1,PHASE2 · COMPLETED · sponsor: **Beijing 302 Hospital** · enrollment: 90 (actual)

## Conditions studied

- Drug-induced Liver Injury,Chronic

## Interventions

- **DRUG:** 36 Weeks Methylprednisolone
- **DRUG:** 48 weeks Methylprednisolone

## Key facts

- **NCT ID:** NCT03266146
- **Lead sponsor:** Beijing 302 Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-02
- **Primary completion:** 2023-01-31
- **Final completion:** 2023-01-31
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2023-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03266146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03266146, "36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent DILI". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03266146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*